Raras
Buscar doenças, sintomas, genes...
Distrofia da retina, genética
ORPHA:71862CID-10 · H35.5DOENÇA RARA

Um caso de degeneração da retina causada por uma modificação herdada do genoma do indivíduo.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Um caso de degeneração da retina causada por uma modificação herdada do genoma do indivíduo.

Medicamentos
8 registrados
PEGAPTANIB SODIUM, RANIBIZUMAB, AFLIBERCEPT

Tem tratamento?

8 medicamentos registrados
Ver detalhes, fases e interações →
PEGAPTANIB SODIUMRANIBIZUMABAFLIBERCEPTBROLUCIZUMABFARICIMABVORETIGENE NEPARVOVECBEVACIZUMABTRIAMCINOLONE ACETONIDE
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H35.5
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
169 sintomas
🧠
Neurológico
61 sintomas
🦴
Ossos e articulações
41 sintomas
🧬
Pele e cabelo
25 sintomas
📏
Crescimento
24 sintomas
😀
Face
20 sintomas

+ 244 sintomas em outras categorias

Características mais comuns

Retinopatia
Lesão macular hiperautofluorescente
Mancha algodonosa retiniana
Anel perifoveal de hiperautofluorescência
Astigmatismo misto
Reflexo foveal opaco
679sintomas
Sem dados (679)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 679 características clínicas mais associadas, ordenadas por frequência.

RetinopatiaRetinopathy
Lesão macular hiperautofluorescenteHyperautofluorescent macular lesion
Mancha algodonosa retinianaRetinal cotton wool spot
Anel perifoveal de hiperautofluorescênciaPerifoveal ring of hyperautofluorescence
Astigmatismo mistoMixed astigmatism

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa17
Últimos 10 anos1publicações
Pico20091 papers
Linha do tempo
201020202009Hoje · 2026
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

80 genes identificados com associação a esta condição.

ROM1Rod outer segment membrane protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in rod outer segment (ROS) morphogenesis (By similarity). May play a role with PRPH2 in the maintenance of the structure of ROS curved disks (By similarity). Plays a role in the organization of the ROS and maintenance of ROS disk diameter (By similarity). Involved in the maintenance of the retina outer nuclear layer (By similarity)

LOCALIZAÇÃO

Photoreceptor inner segment membranePhotoreceptor outer segment membrane

MECANISMO DE DOENÇA

Retinitis pigmentosa 7

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
56.0 TPM
Substância negra
34.4 TPM
Cérebro - Amígdala
24.2 TPM
Hipocampo
23.2 TPM
Cérebro - Hemisfério cerebelar
22.3 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 7retinitis pigmentosa
HGNC:10254UniProt:Q03395
ADAM9Disintegrin and metalloproteinase domain-containing protein 9Candidate gene tested inTolerante
FUNÇÃO

Metalloprotease that cleaves and releases a number of molecules with important roles in tumorigenesis and angiogenesis, such as TEK, KDR, EPHB4, CD40, VCAM1 and CDH5. May mediate cell-cell, cell-matrix interactions and regulate the motility of cells via interactions with integrins May act as alpha-secretase for amyloid precursor protein (APP)

LOCALIZAÇÃO

Cell membraneSecreted

VIAS BIOLÓGICAS (1)
Collagen degradation
MECANISMO DE DOENÇA

Cone-rod dystrophy 9

An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
cone-rod dystrophy 9cone-rod dystrophy
HGNC:216UniProt:Q13443
OPN1LWLong-wave-sensitive opsin 1Candidate gene tested inAltamente restrito
FUNÇÃO

Visual pigments are the light-absorbing molecules that mediate vision. They consist of an apoprotein, opsin, covalently linked to cis-retinal

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (3)
OpsinsG alpha (i) signalling eventsThe retinoid cycle in cones (daylight vision)
MECANISMO DE DOENÇA

Colorblindness, partial, protan series

An X-linked color vision defect characterized by a dichromasy in which red and green are confused, with loss of luminance and shift of brightness and hue curves toward the short wave end of the spectrum. Dichromasy is due to the use of only two types of photoreceptors, blue plus red in deuteranopia and blue plus green in protanopia.

EXPRESSÃO TECIDUAL(Não detectado)
Testículo
0.1 TPM
Rim - Medula
0.0 TPM
OUTRAS DOENÇAS (4)
red color blindnessblue cone monochromacyX-linked cone dysfunction syndrome with myopiacone-rod dystrophy
HGNC:9936UniProt:P04000
ARHGEF18Rho guanine nucleotide exchange factor 18Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts as a guanine nucleotide exchange factor (GEF) for RhoA GTPases. Its activation induces formation of actin stress fibers. Also acts as a GEF for RAC1, inducing production of reactive oxygen species (ROS). Does not act as a GEF for CDC42. The G protein beta-gamma (Gbetagamma) subunits of heterotrimeric G proteins act as activators, explaining the integrated effects of LPA and other G-protein coupled receptor agonists on actin stress fiber formation, cell shape change and ROS production. Requi

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeletonCell membraneApical cell membrane

VIAS BIOLÓGICAS (1)
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
MECANISMO DE DOENÇA

Retinitis pigmentosa 78

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP78 inheritance is autosomal recessive.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 78retinitis pigmentosa
HGNC:17090UniProt:Q6ZSZ5
RHORhodopsinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Photoreceptor required for image-forming vision at low light intensity (PubMed:7846071, PubMed:8107847). Required for photoreceptor cell viability after birth (PubMed:12566452, PubMed:2215617). Light-induced isomerization of the chromophore 11-cis-retinal to all-trans-retinal triggers a conformational change that activates signaling via G-proteins (PubMed:26200343, PubMed:28524165, PubMed:28753425, PubMed:8107847). Subsequent receptor phosphorylation mediates displacement of the bound G-protein

LOCALIZAÇÃO

MembraneCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (4)
OpsinsG alpha (i) signalling eventsThe canonical retinoid cycle in rods (twilight vision)Inactivation, recovery and regulation of the phototransduction cascade
MECANISMO DE DOENÇA

Retinitis pigmentosa 4

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Frontal Cortex BA9
0.5 TPM
Cerebelo
0.5 TPM
Cérebro - Hemisfério cerebelar
0.5 TPM
Córtex cerebral
0.5 TPM
Testículo
0.2 TPM
OUTRAS DOENÇAS (6)
retinitis pigmentosa 4fundus albipunctatuscongenital stationary night blindness autosomal dominant 1retinitis pigmentosa
HGNC:10012UniProt:P08100
CDH3Cadherin-3Candidate gene tested inTolerante
FUNÇÃO

Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
Adherens junctions interactions
MECANISMO DE DOENÇA

Hypotrichosis congenital with juvenile macular dystrophy

A disorder characterized by congenital hypotrichosis, early hair loss, and severe degenerative changes of the retinal macula that culminate in blindness during the second to third decade of life.

OUTRAS DOENÇAS (2)
congenital hypotrichosis with juvenile macular dystrophyEEM syndrome
HGNC:1762UniProt:P22223
CEP290Centrosomal protein of 290 kDaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in early and late steps in cilia formation. Its association with CCP110 is required for inhibition of primary cilia formation by CCP110 (PubMed:18694559). May play a role in early ciliogenesis in the disappearance of centriolar satellites and in the transition of primary ciliar vesicles (PCVs) to capped ciliary vesicles (CCVs). Required for the centrosomal recruitment of RAB8A and for the targeting of centriole satellite proteins to centrosomes such as of PCM1 (PubMed:24421332). Require

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satelliteNucleusCell projection, ciliumCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centrioleCytoplasmic vesicle

VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Joubert syndrome 5

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. Joubert syndrome type 5 shares the neurologic and neuroradiologic features of Joubert syndrome together with severe retinal dystrophy and/or progressive renal failure characterized by nephronophthisis.

OUTRAS DOENÇAS (10)
Senior-Loken syndrome 6Leber congenital amaurosis 10Joubert syndrome 5Meckel syndrome, type 4
HGNC:29021UniProt:O15078
ABCA4Retinal-specific phospholipid-transporting ATPase ABCA4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Flippase that catalyzes in an ATP-dependent manner the transport of retinal-phosphatidylethanolamine conjugates like 11-cis and all-trans isomers of N-retinylidene-phosphatidylethanolamine (N-Ret-PE) from the lumen to the cytoplasmic leaflet of photoreceptor outer segment disk membranes, where 11-cis-retinylidene-phosphatidylethanolamine is then isomerized to its all-trans isomer and reduced by RDH8 to produce all-trans-retinol. This transport activity ensures that all-trans-retinal generated fr

LOCALIZAÇÃO

MembraneEndoplasmic reticulumCytoplasmic vesicleCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (2)
The canonical retinoid cycle in rods (twilight vision)ABC-family proteins mediated transport
MECANISMO DE DOENÇA

Stargardt disease 1

An autosomal recessive form of Stargardt disease, a retinal degenerative disease characterized by macular dystrophy, progressive bilateral atrophy of the foveal retinal pigment epithelium, and accumulation of fluorescent flecks around the macula and/or in the central and near-peripheral areas of the retina. STGD1 patients typically lose central vision in their first or second decade of life.

OUTRAS DOENÇAS (8)
severe early-childhood-onset retinal dystrophyretinitis pigmentosa 19cone-rod dystrophy 3ABCA4-related retinopathy
HGNC:34UniProt:P78363
RPGRX-linked retinitis pigmentosa GTPase regulatorDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acts as a guanine-nucleotide releasing factor (GEF) for RAB8A and RAB37 by promoting the conversion of inactive RAB-GDP to the active form RAB-GTP (PubMed:20631154). GEF activity towards RAB8A may facilitate ciliary trafficking by modulating ciliary intracellular localization of RAB8A (PubMed:20631154). GEF activity towards RAB37 maintains autophagic homeostasis and retinal function (By similarity). Involved in photoreceptor integrity (By similarity). May control cilia formation by regulating ac

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, flagellum axonemeGolgi apparatusCell projection, ciliumCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, cilium axoneme

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateAnchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Retinitis pigmentosa 3

An X-linked retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. In RP3, affected males have a severe phenotype, and carrier females show a wide spectrum of clinical features ranging from completely asymptomatic to severe retinitis pigmentosa. Heterozygous women can manifest a form of choroidoretinal degeneration which is distinguished from other types by the absence of visual defects in the presence of a brilliant, scintillating, golden-hued, patchy appearance most striking around the macula, called a tapetal-like retinal reflex.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
19.9 TPM
Nervo tibial
17.6 TPM
Tecido adiposo
15.5 TPM
Fallopian Tube
14.7 TPM
Pulmão
14.3 TPM
OUTRAS DOENÇAS (9)
macular degeneration, X-linked atrophicretinitis pigmentosa 3obsolete primary ciliary dyskinesia-retinitis pigmentosa syndromeX-linked cone-rod dystrophy 1
HGNC:10295UniProt:Q92834
AHRAryl hydrocarbon receptorCandidate gene tested inRestrito
FUNÇÃO

Ligand-activated transcription factor that enables cells to adapt to changing conditions by sensing compounds from the environment, diet, microbiome and cellular metabolism, and which plays important roles in development, immunity and cancer (PubMed:23275542, PubMed:30373764, PubMed:32818467, PubMed:7961644). Upon ligand binding, translocates into the nucleus, where it heterodimerizes with ARNT and induces transcription by binding to xenobiotic response elements (XRE) (PubMed:23275542, PubMed:30

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
Aryl hydrocarbon receptor signalling
MECANISMO DE DOENÇA

Retinitis pigmentosa 85

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP85 is an autosomal recessive form manifesting as early-onset progressive difficulty to adapt in dim light and gradually decreasing visual acuity in both eyes.

OUTRAS DOENÇAS (3)
foveal hypoplasia 3retinitis pigmentosa 85retinitis pigmentosa
HGNC:348UniProt:P35869
TINF2TERF1-interacting nuclear factor 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the shelterin complex (telosome) that is involved in the regulation of telomere length and protection. Shelterin associates with arrays of double-stranded TTAGGG repeats added by telomerase and protects chromosome ends; without its protective activity, telomeres are no longer hidden from the DNA damage surveillance and chromosome ends are inappropriately processed by DNA repair pathways. Plays a role in shelterin complex assembly. Isoform 1 may have additional role in tethering telo

LOCALIZAÇÃO

NucleusChromosome, telomereNucleus matrix

VIAS BIOLÓGICAS (10)
DNA Damage/Telomere Stress Induced SenescencePackaging Of Telomere EndsMeiotic synapsisInhibition of DNA recombination at telomereTelomere C-strand (Lagging Strand) Synthesis
MECANISMO DE DOENÇA

Dyskeratosis congenita, autosomal dominant, 3

A rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
88.3 TPM
Nervo tibial
85.3 TPM
Artéria tibial
82.2 TPM
Baço
82.0 TPM
Glândula adrenal
81.4 TPM
OUTRAS DOENÇAS (4)
Revesz syndromedyskeratosis congenita, autosomal dominant 3dyskeratosis congenitaHoyeraal-Hreidarsson syndrome
HGNC:11824UniProt:Q9BSI4
BBS2BBSome complex member BBS2Candidate gene tested inTolerante
FUNÇÃO

The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the c

LOCALIZAÇÃO

Cell projection, cilium membraneCytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite

VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
MECANISMO DE DOENÇA

Bardet-Biedl syndrome 2

A syndrome characterized by usually severe pigmentary retinopathy, early-onset obesity, polydactyly, hypogenitalism, renal malformation and intellectual disability. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease.

OUTRAS DOENÇAS (4)
Bardet-Biedl syndrome 2retinitis pigmentosa 74retinitis pigmentosaBardet-Biedl syndrome
HGNC:967UniProt:Q9BXC9
IDH3AIsocitrate dehydrogenase [NAD] subunit alpha, mitochondrialCandidate gene tested inTolerante
FUNÇÃO

Catalytic subunit of the enzyme which catalyzes the decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have considerable basal activity but the full activity of the heterotetramer (containing two subunits of IDH3A, one of IDH3B and one of IDH3G) requires the assembly and cooperative function of both heterodimers

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (2)
Citric acid cycle (TCA cycle)Mitochondrial protein degradation
MECANISMO DE DOENÇA

Retinitis pigmentosa 90

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. RP90 is an autosomal recessive form.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
41.9 TPM
Coração - Átrio
30.6 TPM
Artéria tibial
26.4 TPM
Cérebro - Hemisfério cerebelar
25.3 TPM
Músculo esquelético
25.2 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 90retinitis pigmentosa
HGNC:5384UniProt:P50213
ARL6ADP-ribosylation factor-like protein 6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in membrane protein trafficking at the base of the ciliary organelle. Mediates recruitment onto plasma membrane of the BBSome complex which would constitute a coat complex required for sorting of specific membrane proteins to the primary cilia (PubMed:20603001). Together with BBS1, is necessary for correct trafficking of PKD1 to primary cilia (By similarity). Together with the BBSome complex and LTZL1, controls SMO ciliary trafficking and contributes to the sonic hedgehog (SHH) pathway

LOCALIZAÇÃO

Cell projection, cilium membraneCytoplasm, cytoskeleton, cilium axonemeCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
MECANISMO DE DOENÇA

Bardet-Biedl syndrome 3

A syndrome characterized by usually severe pigmentary retinopathy, early-onset obesity, polydactyly, hypogenitalism, renal malformation and intellectual disability. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease.

OUTRAS DOENÇAS (5)
retinitis pigmentosa 55Bardet-Biedl syndrome 3retinitis pigmentosaBardet-Biedl syndrome
HGNC:13210UniProt:Q9H0F7
TOPORSE3 ubiquitin-protein ligase ToporsDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Functions as an E3 ubiquitin-protein ligase and as an E3 SUMO1-protein ligase. Probable tumor suppressor involved in cell growth, cell proliferation and apoptosis that regulates p53/TP53 stability through ubiquitin-dependent degradation. May regulate chromatin modification through sumoylation of several chromatin modification-associated proteins. May be involved in DNA damage-induced cell death through IKBKE sumoylation

LOCALIZAÇÃO

NucleusNucleus, PML body

VIAS BIOLÓGICAS (3)
SUMOylation of immune response proteinsSUMOylation of transcription cofactorsSUMOylation of SUMOylation proteins
MECANISMO DE DOENÇA

Retinitis pigmentosa 31

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
31.6 TPM
Ovário
23.5 TPM
Fibroblastos
21.4 TPM
Fallopian Tube
18.9 TPM
Cérebro - Hemisfério cerebelar
18.9 TPM
OUTRAS DOENÇAS (3)
retinitis pigmentosa 31retinitis pigmentosaorofaciodigital syndrome type 6
HGNC:21653UniProt:Q9NS56
PRCDPhotoreceptor disk component PRCDCandidate gene tested inTolerante
FUNÇÃO

Involved in vision

LOCALIZAÇÃO

Cell projection, cilium, photoreceptor outer segmentMembraneEndoplasmic reticulumGolgi apparatus

MECANISMO DE DOENÇA

Retinitis pigmentosa 36

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
21.0 TPM
Cérebro - Hemisfério cerebelar
20.5 TPM
Brain Spinal cord cervical c-1
8.0 TPM
Cervix Endocervix
6.6 TPM
Cervix Ectocervix
6.6 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 36retinitis pigmentosa
HGNC:32528UniProt:Q00LT1
SLC7A14Solute carrier family 7 member 14Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Imports 4-aminobutanoate (GABA) into lysosomes. May act as a GABA sensor that regulates mTORC2-dependent INS signaling and gluconeogenesis. The transport mechanism and substrate selectivity remain to be elucidated

LOCALIZAÇÃO

Lysosome membrane

MECANISMO DE DOENÇA

Retinitis pigmentosa 68

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
21.6 TPM
Cerebelo
15.0 TPM
Pituitária
14.2 TPM
Hipotálamo
9.8 TPM
Brain Spinal cord cervical c-1
9.2 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
retinitis pigmentosa 68retinitis pigmentosa
HGNC:29326UniProt:Q8TBB6
CACNA1FVoltage-dependent L-type calcium channel subunit alpha-1FDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1F gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkyla

LOCALIZAÇÃO

Membrane

MECANISMO DE DOENÇA

Night blindness, congenital stationary, 2A

A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia.

OUTRAS DOENÇAS (4)
congenital stationary night blindness 2AX-linked cone-rod dystrophy 3Aland island eye diseasecone-rod dystrophy
HGNC:1393UniProt:O60840
OATOrnithine aminotransferase, mitochondrialCandidate gene tested inTolerante
FUNÇÃO

Catalyzes the reversible interconversion of L-ornithine and 2-oxoglutarate to L-glutamate semialdehyde and L-glutamate

LOCALIZAÇÃO

Mitochondrion matrix

VIAS BIOLÓGICAS (1)
Glutamate and glutamine metabolism
MECANISMO DE DOENÇA

Hyperornithinemia with gyrate atrophy of choroid and retina

A disorder clinically characterized by a triad of progressive chorioretinal degeneration, early cataract formation, and type II muscle fiber atrophy. Characteristic chorioretinal atrophy with progressive constriction of the visual fields leads to blindness at the latest during the sixth decade of life. Patients generally have normal intelligence.

EXPRESSÃO TECIDUAL(Ubíquo)
Intestino delgado
165.3 TPM
Fibroblastos
139.5 TPM
Aorta
118.9 TPM
Artéria tibial
116.9 TPM
Cervix Endocervix
110.6 TPM
OUTRAS DOENÇAS (1)
ornithine aminotransferase deficiency
HGNC:8091UniProt:P04181
PRPF31U4/U6 small nuclear ribonucleoprotein Prp31Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Involved in pre-mRNA splicing as component of the spliceosome (PubMed:11867543, PubMed:20118938, PubMed:28781166). Required for the assembly of the U4/U5/U6 tri-snRNP complex, one of the building blocks of the spliceosome (PubMed:11867543)

LOCALIZAÇÃO

NucleusNucleus speckleNucleus, Cajal body

VIAS BIOLÓGICAS (1)
mRNA Splicing - Major Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 11

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
81.5 TPM
Útero
81.1 TPM
Fibroblastos
77.6 TPM
Linfócitos
76.5 TPM
Cervix Ectocervix
76.4 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 11retinitis pigmentosa
HGNC:15446UniProt:Q8WWY3
CYP4V2Cytochrome P450 4V2Candidate gene tested inTolerante
FUNÇÃO

A cytochrome P450 monooxygenase involved in fatty acid metabolism in the eye. Catalyzes the omega-hydroxylation of polyunsaturated fatty acids (PUFAs) docosahexaenoate (DHA) and its precursor eicosapentaenoate (EPA), and may contribute to the homeostasis of these retinal PUFAs (PubMed:22772592). Omega hydroxylates saturated fatty acids such as laurate, myristate and palmitate, the catalytic efficiency decreasing in the following order: myristate > laurate > palmitate (C14>C12>C16) (PubMed:196612

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (2)
The canonical retinoid cycle in rods (twilight vision)Endogenous sterols
MECANISMO DE DOENÇA

Bietti crystalline corneoretinal dystrophy

An autosomal recessive ocular disease characterized by retinal degeneration and marginal corneal dystrophy. Typical features include multiple glistening intraretinal crystals scattered over the fundus, a characteristic degeneration of the retina, and sclerosis of the choroidal vessels, ultimately resulting in progressive night blindness and constriction of the visual field. Most patients have similar crystals at the corneoscleral limbus. Patients develop decreased vision, nyctalopia, and paracentral scotomata between the 2nd and 4th decade of life. Later, they develop peripheral visual field loss and marked visual impairment, usually progressing to legal blindness by the 5th or 6th decade of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
41.0 TPM
Nervo tibial
30.3 TPM
Glândula adrenal
29.0 TPM
Pituitária
25.4 TPM
Tireoide
23.5 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
Bietti crystalline corneoretinal dystrophy
HGNC:23198UniProt:Q6ZWL3
LRIT3Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in the synapse formation and synaptic transmission between cone photoreceptor cells and retinal bipolar cells (By similarity). Required for normal transmission of a light-evoked stimulus from the cone photoreceptor cells to the ON-bipolar cells and ON-ganglion cells in the inner retina (PubMed:28334377). Required in retinal ON-bipolar cells for normal localization of the cation channel TRPM1 at dendrite tips (By similarity). Seems to play a specific role in synaptic contacts made by

LOCALIZAÇÃO

Cell projection, dendritePerikaryonEndoplasmic reticulum membrane

MECANISMO DE DOENÇA

Night blindness, congenital stationary, 1F

An autosomal recessive form of congenital stationary night blindness, a non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia.

EXPRESSÃO TECIDUAL(Baixa expressão)
Cerebelo
1.7 TPM
Cérebro - Hemisfério cerebelar
1.7 TPM
Nervo tibial
1.5 TPM
Testículo
1.2 TPM
Cervix Endocervix
1.0 TPM
OUTRAS DOENÇAS (1)
congenital stationary night blindness 1F
HGNC:24783UniProt:Q3SXY7
GRK1Rhodopsin kinase GRK1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Retina-specific kinase involved in the signal turnoff via phosphorylation of rhodopsin (RHO), the G protein- coupled receptor that initiates the phototransduction cascade (PubMed:15946941). This rapid desensitization is essential for scotopic vision and permits rapid adaptation to changes in illumination (By similarity). May play a role in the maintenance of the outer nuclear layer in the retina (By similarity)

LOCALIZAÇÃO

MembraneCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (1)
Inactivation, recovery and regulation of the phototransduction cascade
MECANISMO DE DOENÇA

Night blindness, congenital stationary, Oguchi type 2

A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia. Congenital stationary night blindness Oguchi type is associated with fundus discoloration and abnormally slow dark adaptation.

EXPRESSÃO TECIDUAL(Baixa expressão)
Tireoide
4.2 TPM
Testículo
0.6 TPM
Pituitária
0.2 TPM
Cerebelo
0.1 TPM
Cérebro - Hemisfério cerebelar
0.1 TPM
OUTRAS DOENÇAS (2)
Oguchi disease-2Oguchi disease
HGNC:10013UniProt:Q15835
RDH5Retinol dehydrogenase 5Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the oxidation of cis-isomers of retinol, including 11-cis-, 9-cis-, and 13-cis-retinol in an NAD-dependent manner (PubMed:10588954, PubMed:11675386, PubMed:9115228, PubMed:9931293). Has no activity towards all-trans retinal (By similarity). Plays a significant role in 11-cis retinol oxidation in the retinal pigment epithelium cells (RPE). Also recognizes steroids (androsterone, androstanediol) as its substrates (PubMed:29541409, PubMed:9931293)

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (2)
The canonical retinoid cycle in rods (twilight vision)RA biosynthesis pathway
MECANISMO DE DOENÇA

Fundus albipunctatus

A form of fleck retina disease characterized by discrete uniform white dots over the entire fundus with greatest density in the mid-periphery and no macular involvement. Night blindness occurs. Inheritance can be autosomal dominant or autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Tecido adiposo
71.7 TPM
Adipose Visceral Omentum
58.6 TPM
Mama
35.5 TPM
Artéria coronária
30.8 TPM
Fígado
30.8 TPM
OUTRAS DOENÇAS (2)
fundus albipunctatusretinitis punctata albescens
HGNC:9940UniProt:Q92781
CRXCone-rod homeobox proteinCandidate gene tested inModerado
FUNÇÃO

Transcription factor that binds and transactivates the sequence 5'-TAATC[CA]-3' which is found upstream of several photoreceptor-specific genes, including the opsin genes. Acts synergistically with other transcription factors, such as NRL, RORB and RAX, to regulate photoreceptor cell-specific gene transcription. Essential for the maintenance of mammalian photoreceptors

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Leber congenital amaurosis 7

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Não detectado)
Testículo
0.1 TPM
Fígado
0.1 TPM
Ovário
0.0 TPM
Cerebelo
0.0 TPM
Cérebro - Hemisfério cerebelar
0.0 TPM
OUTRAS DOENÇAS (5)
Leber congenital amaurosis 7cone-rod dystrophy 2retinitis pigmentosacone-rod dystrophy
HGNC:2383UniProt:O43186
PCAREPhotoreceptor cilium actin regulatorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays an essential role for normal photoreceptor cell maintenance and vision

LOCALIZAÇÃO

Cell projection, cilium, photoreceptor outer segmentPhotoreceptor inner segment

MECANISMO DE DOENÇA

Retinitis pigmentosa 54

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 54retinitis pigmentosa
HGNC:34383UniProt:A6NGG8
TLCD3BCeramide synthaseCandidate gene tested inModerado
FUNÇÃO

Involved in ceramide synthesis

LOCALIZAÇÃO

Golgi apparatus membraneEndoplasmic reticulum membrane

MECANISMO DE DOENÇA

Cone-rod dystrophy 22

An autosomal recessive form of cone-rod dystrophy, an inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

OUTRAS DOENÇAS (2)
cone-rod dystrophy 22cone-rod dystrophy
HGNC:25295UniProt:Q71RH2
GNAT2Guanine nucleotide-binding protein G(t) subunit alpha-2Candidate gene tested inTolerante
FUNÇÃO

Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. Transducin is an amplifier and one of the transducers of a visual impulse that performs the coupling between rhodopsin and cGMP-phosphodiesterase

LOCALIZAÇÃO

Cell projection, cilium, photoreceptor outer segmentPhotoreceptor inner segment

VIAS BIOLÓGICAS (2)
Ca2+ pathwayG alpha (i) signalling events
MECANISMO DE DOENÇA

Achromatopsia 4

An ocular stationary disorder due to the absence of functioning cone photoreceptors in the retina. It is characterized by total colorblindness, low visual acuity, photophobia and nystagmus.

OUTRAS DOENÇAS (3)
achromatopsia 4cone dystrophyachromatopsia
HGNC:4394UniProt:P19087
CNGA3Cyclic nucleotide-gated channel alpha-3Candidate gene tested inTolerante
FUNÇÃO

Pore-forming subunit of the cone cyclic nucleotide-gated channel. Mediates cone photoresponses at bright light converting transient changes in intracellular cGMP levels into electrical signals. In the dark, cGMP levels are high and keep the channel open enabling a steady inward current carried by Na(+) and Ca(2+) ions that leads to membrane depolarization and neurotransmitter release from synaptic terminals. Upon photon absorption cGMP levels decline leading to channel closure and membrane hyper

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Achromatopsia 2

An autosomal recessive, ocular stationary disorder due to the absence of functioning cone photoreceptors in the retina. It is characterized by total colorblindness, low visual acuity, photophobia and nystagmus.

OUTRAS DOENÇAS (3)
achromatopsia 2cone-rod dystrophyachromatopsia
HGNC:2150UniProt:Q16281
BEST1Bestrophin-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Ligand-gated anion channel that allows the movement of anions across cell membranes when activated by calcium (Ca2+) (PubMed:11904445, PubMed:12907679, PubMed:18179881, PubMed:18400985, PubMed:19853238, PubMed:21330666, PubMed:26200502, PubMed:26720466, PubMed:35789156). Allows the movement of chloride and hydrogencarbonate (PubMed:11904445, PubMed:12907679, PubMed:18179881, PubMed:18400985, PubMed:19853238, PubMed:21330666, PubMed:26200502, PubMed:26720466, PubMed:35789156). Found in a partiall

LOCALIZAÇÃO

Cell membraneBasolateral cell membrane

VIAS BIOLÓGICAS (1)
Stimuli-sensing channels
MECANISMO DE DOENÇA

Macular dystrophy, vitelliform, 2

An autosomal dominant form of macular degeneration that usually begins in childhood or adolescence. VMD2 is characterized by typical 'egg-yolk' macular lesions due to abnormal accumulation of lipofuscin within and beneath the retinal pigment epithelium cells. Progression of the disease leads to destruction of the retinal pigment epithelium and vision loss.

VIAS REACTOME (1)
OUTRAS DOENÇAS (8)
vitelliform macular dystrophy 2retinitis pigmentosa 50autosomal dominant vitreoretinochoroidopathyautosomal recessive bestrophinopathy
HGNC:12703UniProt:O76090
CERKLCeramide kinase-like proteinCandidate gene tested inTolerante
FUNÇÃO

Has no detectable ceramide-kinase activity. Overexpression of CERKL protects cells from apoptosis in oxidative stress conditions

LOCALIZAÇÃO

CytoplasmNucleus, nucleolusGolgi apparatus, trans-Golgi networkEndoplasmic reticulum

MECANISMO DE DOENÇA

Retinitis pigmentosa 26

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 26retinitis pigmentosa
HGNC:21699UniProt:Q49MI3
SPATA7Spermatogenesis-associated protein 7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in the maintenance of both rod and cone photoreceptor cells (By similarity). It is required for recruitment and proper localization of RPGRIP1 to the photoreceptor connecting cilium (CC), as well as photoreceptor-specific localization of proximal CC proteins at the distal CC (By similarity). Maintenance of protein localization at the photoreceptor-specific distal CC is essential for normal microtubule stability and to prevent photoreceptor degeneration (By similarity)

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium axonemeCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeletonCell projection, cilium, photoreceptor outer segment

MECANISMO DE DOENÇA

Leber congenital amaurosis 3

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
61.8 TPM
Cérebro - Hemisfério cerebelar
16.1 TPM
Ovário
14.7 TPM
Pituitária
14.6 TPM
Cerebelo
13.8 TPM
OUTRAS DOENÇAS (4)
Leber congenital amaurosis 3severe early-childhood-onset retinal dystrophyLeber congenital amaurosisretinitis pigmentosa
HGNC:20423UniProt:Q9P0W8
PDE6GRetinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gammaCandidate gene tested inTolerante
FUNÇÃO

Participates in processes of transmission and amplification of the visual signal. cGMP-PDEs are the effector molecules in G-protein-mediated phototransduction in vertebrate rods and cones

LOCALIZAÇÃO

VIAS BIOLÓGICAS (2)
Inactivation, recovery and regulation of the phototransduction cascadeActivation of the phototransduction cascade
MECANISMO DE DOENÇA

Retinitis pigmentosa 57

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Tecido-específico)
Baço
8.5 TPM
Linfócitos
8.0 TPM
Sangue
2.8 TPM
Testículo
2.5 TPM
Rim - Medula
2.3 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 57retinitis pigmentosa
HGNC:8789UniProt:P18545
FAM161AProtein FAM161ACandidate gene tested inTolerante
FUNÇÃO

Involved in ciliogenesis

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium basal bodyCell projection, ciliumCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole

MECANISMO DE DOENÇA

Retinitis pigmentosa 28

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
15.7 TPM
Ovário
10.0 TPM
Pituitária
8.4 TPM
Tireoide
7.0 TPM
Linfócitos
6.5 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 28retinitis pigmentosa
HGNC:25808UniProt:Q3B820
MAKSerine/threonine-protein kinase MAKCandidate gene tested inTolerante
FUNÇÃO

Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Could play an important function in spermatogenesis. May play a role in chromosomal stability in prostate cancer cells

LOCALIZAÇÃO

NucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindleMidbodyCell projection, cilium, photoreceptor outer segmentPhotoreceptor inner segment

VIAS BIOLÓGICAS (2)
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
MECANISMO DE DOENÇA

Retinitis pigmentosa 62

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
15.1 TPM
Sangue
2.7 TPM
Pituitária
1.8 TPM
Fallopian Tube
1.3 TPM
Baço
1.3 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 62retinitis pigmentosa
HGNC:6816UniProt:P20794
IFT140Intraflagellar transport protein 140 homologDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the IFT complex A (IFT-A), a complex required for retrograde ciliary transport and entry into cilia of G protein-coupled receptors (GPCRs) (PubMed:20889716, PubMed:22503633). Plays a pivotal role in proper development and function of ciliated cells through its role in ciliogenesis and/or cilium maintenance (PubMed:22503633). Required for the development and maintenance of the outer segments of rod and cone photoreceptor cells. Plays a role in maintenance and the delivery of opsin to

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, cilium

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateIntraflagellar transport
MECANISMO DE DOENÇA

Short-rib thoracic dysplasia 9 with or without polydactyly

A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome. SRTD9 is characterized by phalangeal cone-shaped epiphyses, chronic renal disease, nearly constant retinal dystrophy, and mild radiographic abnormality of the proximal femur. Occasional features include short stature, cerebellar ataxia, and hepatic fibrosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
59.8 TPM
Testículo
47.9 TPM
Pituitária
34.4 TPM
Ovário
31.1 TPM
Cervix Endocervix
29.6 TPM
OUTRAS DOENÇAS (8)
retinitis pigmentosa 80cranioectodermal dysplasia 5short-rib thoracic dysplasia 9 with or without polydactylyJeune syndrome
HGNC:29077UniProt:Q96RY7
CLDN19Claudin-19Candidate gene tested inTolerante
FUNÇÃO

Forms paracellular channels: coassembles with CLDN16 into tight junction strands with cation-selective channels through the strands, conveying epithelial permeability in a process known as paracellular tight junction permeability (PubMed:18188451, PubMed:28028216). Involved in the maintenance of ion gradients along the nephron. In the thick ascending limb (TAL) of Henle's loop, facilitates sodium paracellular permeability from the interstitial compartment to the lumen, contributing to the lumen-

LOCALIZAÇÃO

Cell junction, tight junctionCell membrane

VIAS BIOLÓGICAS (1)
Tight junction interactions
MECANISMO DE DOENÇA

Hypomagnesemia 5, renal, with or without ocular involvement

A progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis associated with severe ocular abnormalities such as bilateral chorioretinal scars, macular colobomata, significant myopia and nystagmus. The renal phenotype is virtually undistinguishable from that of patients with HOMG3.

OUTRAS DOENÇAS (1)
renal hypomagnesemia 5 with ocular involvement
HGNC:2040UniProt:Q8N6F1
CNGA1Cyclic nucleotide-gated channel alpha-1Candidate gene tested inTolerante
FUNÇÃO

Pore-forming subunit of the rod cyclic nucleotide-gated channel. Mediates rod photoresponses at dim light converting transient changes in intracellular cGMP levels into electrical signals. In the dark, cGMP levels are high and keep the channel open enabling a steady inward current carried by Na(+) and Ca(2+) ions that leads to membrane depolarization and neurotransmitter release from synaptic terminals. Upon photon absorption cGMP levels decline leading to channel closure and membrane hyperpolar

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Inactivation, recovery and regulation of the phototransduction cascadeActivation of the phototransduction cascade
MECANISMO DE DOENÇA

Retinitis pigmentosa 49

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 49retinitis pigmentosa
HGNC:2148UniProt:P29973
HKDC1Hexokinase HKDC1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the phosphorylation of hexose to hexose 6-phosphate, although at very low level compared to other hexokinases (PubMed:30517626). Has low glucose phosphorylating activity compared to other hexokinases (PubMed:30517626). Involved in glucose homeostasis and hepatic lipid accumulation. Required to maintain whole-body glucose homeostasis during pregnancy; however additional evidences are required to confirm this role (By similarity)

LOCALIZAÇÃO

CytoplasmMitochondrion membranePhotoreceptor inner segment

VIAS BIOLÓGICAS (1)
Glycolysis
MECANISMO DE DOENÇA

Retinitis pigmentosa 92

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. RP92 is an autosomal recessive, mild form with onset of night blindness and vision loss in the third to sixth decades of life.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
28.3 TPM
Rim - Medula
10.6 TPM
Rim - Córtex
10.1 TPM
Nervo tibial
9.8 TPM
Tireoide
5.6 TPM
OUTRAS DOENÇAS (1)
retinitis pigmentosa 92
HGNC:HGNC:23302UniProt:Q2TB90
RS1RetinoschisinCandidate gene tested inAltamente restrito
FUNÇÃO

Binds negatively charged membrane lipids, such as phosphatidylserine and phosphoinositides (By similarity). May play a role in cell-cell adhesion processes in the retina, via homomeric interaction between octamers present on the surface of two neighboring cells (PubMed:27114531). Required for normal structure and function of the retina (PubMed:19093009)

LOCALIZAÇÃO

SecretedCell membrane

MECANISMO DE DOENÇA

Retinoschisis juvenile X-linked 1

A vitreo-retinal dystrophy characterized by macular pathology and by splitting of the superficial layer of the retina. Macular changes are present in almost all cases. In the fundi, radially oriented intraretinal foveomacular cysts are seen in a spoke-wheel configuration, with the absence of foveal reflex in most cases. In addition, approximately half of cases have bilateral peripheral retinoschisis in the inferotemporal part of the retina. Aside from the typical fundus appearance, strabismus, nystagmus, axial hyperopia, defective color vision and foveal ectopy can be present. The most important complications are vitreous hemorrhage, retinal detachment, and neovascular glaucoma.

EXPRESSÃO TECIDUAL(Baixa expressão)
Pulmão
2.2 TPM
Brain Frontal Cortex BA9
1.4 TPM
Córtex cerebral
1.2 TPM
Brain Anterior cingulate cortex BA24
1.0 TPM
Brain Caudate basal ganglia
1.0 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
X-linked retinoschisis
HGNC:10457UniProt:O15537
RPE65Retinoid isomerohydrolaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Critical isomerohydrolase in the retinoid cycle involved in regeneration of 11-cis-retinal, the chromophore of rod and cone opsins. Catalyzes the cleavage and isomerization of all-trans-retinyl fatty acid esters to 11-cis-retinol which is further oxidized by 11-cis retinol dehydrogenase to 11-cis-retinal for use as visual chromophore (PubMed:16116091). Essential for the production of 11-cis retinal for both rod and cone photoreceptors (PubMed:17848510). Also capable of catalyzing the isomerizati

LOCALIZAÇÃO

CytoplasmCell membraneMicrosome membrane

VIAS BIOLÓGICAS (1)
The canonical retinoid cycle in rods (twilight vision)
MECANISMO DE DOENÇA

Leber congenital amaurosis 2

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Baixa expressão)
Substância negra
4.6 TPM
Hipotálamo
2.6 TPM
Brain Spinal cord cervical c-1
0.8 TPM
Próstata
0.6 TPM
Hipocampo
0.5 TPM
OUTRAS DOENÇAS (7)
retinitis pigmentosa 20Leber congenital amaurosis 2retinitis pigmentosa 87 with choroidal involvementRPE65-related recessive retinopathy
HGNC:10294UniProt:Q16518
MFSD8Major facilitator superfamily domain-containing protein 8Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Outward-rectifying chloride channel involved in endolysosomal chloride homeostasis, membrane fusion and function. Conducts chloride currents up to hundreds of picoamperes. Regulates lysosomal calcium content by reducing the lysosomal membrane potential, thereby activating TRPML1 channel and further release of lysosomal calcium ions. Regulates the pH in endolysosomal compartments and may contribute to progressive acidification from endosome to lysosome. Permeable to other halides such as iodide a

LOCALIZAÇÃO

Endosome membraneLysosome membrane

MECANISMO DE DOENÇA

Ceroid lipofuscinosis, neuronal, 7

A form of neuronal ceroid lipofuscinosis with onset in early childhood. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment patterns observed most often in neuronal ceroid lipofuscinosis type 7 comprise mixed combinations of granular, curvilinear, fingerprint, and rectilinear profiles.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
20.7 TPM
Ovário
16.8 TPM
Cervix Endocervix
16.7 TPM
Cerebelo
16.7 TPM
Útero
16.4 TPM
OUTRAS DOENÇAS (3)
macular dystrophy with central cone involvementneuronal ceroid lipofuscinosis 7cone-rod dystrophy
HGNC:28486UniProt:Q8NHS3
SAGS-arrestinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Binds to photoactivated, phosphorylated RHO and terminates RHO signaling via G-proteins by competing with G-proteins for the same binding site on RHO (By similarity). May play a role in preventing light-dependent degeneration of retinal photoreceptor cells (PubMed:9565049)

LOCALIZAÇÃO

Cell projection, cilium, photoreceptor outer segmentMembrane

VIAS BIOLÓGICAS (2)
Inactivation, recovery and regulation of the phototransduction cascadeActivation of the phototransduction cascade
MECANISMO DE DOENÇA

Night blindness, congenital stationary, Oguchi type 1

A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia. Congenital stationary night blindness Oguchi type is an autosomal recessive form associated with fundus discoloration and abnormally slow dark adaptation.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
7.2 TPM
Brain Nucleus accumbens basal ganglia
4.1 TPM
Brain Caudate basal ganglia
1.2 TPM
Brain Putamen basal ganglia
0.7 TPM
Cervix Endocervix
0.4 TPM
OUTRAS DOENÇAS (5)
Oguchi disease-1retinitis pigmentosa 47retinitis pigmentosa 96retinitis pigmentosa
HGNC:10521UniProt:P10523
RP1L1Retinitis pigmentosa 1-like 1 proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for the differentiation of photoreceptor cells. Plays a role in the organization of outer segment of rod and cone photoreceptors (By similarity)

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium axonemeCell projection, cilium, photoreceptor outer segment

MECANISMO DE DOENÇA

Occult macular dystrophy

An inherited macular dystrophy characterized by progressive loss of macular function but normal ophthalmoscopic appearance. It is typically characterized by a central cone dysfunction leading to a loss of vision despite normal ophthalmoscopic appearance, normal fluorescein angiography, and normal full-field electroretinogram (ERGs), but the amplitudes of the focal macular ERGs and multifocal ERGs are significantly reduced at the central retina.

EXPRESSÃO TECIDUAL(Baixa expressão)
Skin Sun Exposed Lower leg
0.6 TPM
Skin Not Sun Exposed Suprapubic
0.5 TPM
Pituitária
0.4 TPM
Testículo
0.3 TPM
Vagina
0.3 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (3)
occult macular dystrophyretinitis pigmentosa 88retinitis pigmentosa
HGNC:15946UniProt:Q8IWN7
PRPF3U4/U6 small nuclear ribonucleoprotein Prp3Candidate gene tested inAltamente restrito
FUNÇÃO

Plays a role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex)

LOCALIZAÇÃO

NucleusNucleus speckle

VIAS BIOLÓGICAS (1)
mRNA Splicing - Major Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 18

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
61.9 TPM
Tireoide
59.6 TPM
Nervo tibial
54.5 TPM
Cervix Endocervix
52.6 TPM
Cervix Ectocervix
50.6 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 18retinitis pigmentosa
HGNC:17348UniProt:O43395
FBLN5Fibulin-5Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Essential for elastic fiber formation, is involved in the assembly of continuous elastin (ELN) polymer and promotes the interaction of microfibrils and ELN (PubMed:18185537). Stabilizes and organizes elastic fibers in the skin, lung and vasculature (By similarity). Promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. Vascular ligand for integrin receptors which may play a role in vascular development and remodeling (PubMed:10428823). May act as an adapter th

LOCALIZAÇÃO

SecretedSecreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Molecules associated with elastic fibresElastic fibre formation
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, demyelinating, type 1H

An autosomal dominant demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. CMT1H is characterized by peripheral sensorimotor neuropathy with onset usually in adulthood. Affected individuals present with foot deformities, upper or lower limb sensory disturbances, and motor deficits, mainly impaired gait. Rare patients may have hyperelastic skin or develop age-related macular degeneration.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
795.1 TPM
Fibroblastos
292.3 TPM
Artéria coronária
255.6 TPM
Útero
195.1 TPM
Artéria tibial
192.2 TPM
OUTRAS DOENÇAS (7)
macular degeneration, age-related, 3cutis laxa, autosomal recessive, type 1Acutis laxa, autosomal dominant 2Charcot-Marie-Tooth disease, demyelinating, IIA 1H
HGNC:3602UniProt:Q9UBX5
SNRNP200U5 small nuclear ribonucleoprotein 200 kDa helicaseCandidate gene tested inAltamente restrito
FUNÇÃO

Catalyzes the ATP-dependent unwinding of U4/U6 RNA duplices, an essential step in the assembly of a catalytically active spliceosome (PubMed:35241646). Plays a role in pre-mRNA splicing as a core component of precatalytic, catalytic and postcatalytic spliceosomal complexes (PubMed:28502770, PubMed:28781166, PubMed:29301961, PubMed:29360106, PubMed:29361316, PubMed:30315277, PubMed:30705154, PubMed:30728453). As a component of the minor spliceosome, involved in the splicing of U12-type introns in

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (3)
mRNA Splicing - Major PathwayDengue Virus-Host InteractionsmRNA Splicing - Minor Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 33

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
153.3 TPM
Ovário
132.5 TPM
Útero
119.1 TPM
Cervix Endocervix
112.7 TPM
Cérebro - Hemisfério cerebelar
109.0 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 33retinitis pigmentosa
HGNC:30859UniProt:O75643
LCA5LebercilinCandidate gene tested inTolerante
FUNÇÃO

Involved in intraflagellar protein (IFT) transport in photoreceptor cilia. Plays a role in the ciliary transport of photoreceptors outer segment proteins

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasm, cytoskeleton, cilium axonemeCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, cilium

MECANISMO DE DOENÇA

Leber congenital amaurosis 5

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
8.4 TPM
Cervix Endocervix
8.0 TPM
Fallopian Tube
7.9 TPM
Útero
7.7 TPM
Ovário
7.4 TPM
OUTRAS DOENÇAS (3)
Leber congenital amaurosis 5severe early-childhood-onset retinal dystrophyLeber congenital amaurosis
HGNC:31923UniProt:Q86VQ0
PROM1Prominin-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May play a role in cell differentiation, proliferation and apoptosis (PubMed:24556617). Binds cholesterol in cholesterol-containing plasma membrane microdomains and may play a role in the organization of the apical plasma membrane in epithelial cells. During early retinal development acts as a key regulator of disk morphogenesis. Involved in regulation of MAPK and Akt signaling pathways. In neuroblastoma cells suppresses cell differentiation such as neurite outgrowth in a RET-dependent manner (P

LOCALIZAÇÃO

Apical cell membraneCell projection, microvillus membraneCell projection, cilium, photoreceptor outer segmentEndoplasmic reticulumEndoplasmic reticulum-Golgi intermediate compartment

VIAS BIOLÓGICAS (1)
Developmental Lineage of Pancreatic Ductal Cells
MECANISMO DE DOENÇA

Retinitis pigmentosa 41

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula salivar
69.0 TPM
Rim - Medula
33.8 TPM
Cólon transverso
13.8 TPM
Intestino delgado
11.7 TPM
Testículo
8.3 TPM
OUTRAS DOENÇAS (7)
Stargardt disease 4retinitis pigmentosa 41retinal macular dystrophy type 2cone-rod dystrophy 12
HGNC:9454UniProt:O43490
PRPH2Peripherin-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Essential for retina photoreceptor outer segment disk morphogenesis, may also play a role with ROM1 in the maintenance of outer segment disk structure (By similarity). Required for the maintenance of retinal outer nuclear layer thickness (By similarity). Required for the correct development and organization of the photoreceptor inner segment (By similarity)

LOCALIZAÇÃO

MembraneCell projection, cilium, photoreceptor outer segmentPhotoreceptor inner segment

MECANISMO DE DOENÇA

Retinitis pigmentosa 7

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
9.3 TPM
Ovário
6.8 TPM
Cervix Ectocervix
5.7 TPM
Pituitária
5.3 TPM
Músculo esquelético
5.0 TPM
OUTRAS DOENÇAS (13)
retinitis pigmentosa 7vitelliform macular dystrophy 3fundus albipunctatuschoroidal dystrophy, central areolar 2
HGNC:9942UniProt:P23942
BBS1BBSome complex member BBS1Candidate gene tested inTolerante
FUNÇÃO

The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the c

LOCALIZAÇÃO

Cell projection, cilium membraneCytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite

VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
OUTRAS DOENÇAS (3)
Bardet-Biedl syndrome 1retinitis pigmentosaBardet-Biedl syndrome
HGNC:966UniProt:Q8NFJ9
MERTKTyrosine-protein kinase MerCandidate gene tested inTolerante
FUNÇÃO

Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to several ligands including LGALS3, TUB, TULP1 or GAS6. Regulates many physiological processes including cell survival, migration, differentiation, and phagocytosis of apoptotic cells (efferocytosis). Ligand binding at the cell surface induces autophosphorylation of MERTK on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by l

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Cell surface interactions at the vascular wallDengue Virus Attachment and Entry
MECANISMO DE DOENÇA

Retinitis pigmentosa 38

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
52.4 TPM
Artéria tibial
46.6 TPM
Baço
37.9 TPM
Aorta
33.9 TPM
Testículo
31.7 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 38retinitis pigmentosa
HGNC:7027UniProt:Q12866
KIZCentrosomal protein kizunaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Centrosomal protein required for establishing a robust mitotic centrosome architecture that can endure the forces that converge on the centrosomes during spindle formation. Required for stabilizing the expanded pericentriolar material around the centriole

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, cilium basal body

MECANISMO DE DOENÇA

Retinitis pigmentosa 69

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cólon sigmoide
60.4 TPM
Cervix Endocervix
50.2 TPM
Cervix Ectocervix
38.4 TPM
Ovário
36.5 TPM
Bladder
35.1 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
retinitis pigmentosa 69retinitis pigmentosa
HGNC:15865UniProt:Q2M2Z5
CLEC3BTetranectinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Tetranectin binds to plasminogen and to isolated kringle 4. May be involved in the packaging of molecules destined for exocytosis. Plays a role in retinal function (PubMed:35331648)

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
Platelet degranulation
MECANISMO DE DOENÇA

Macular dystrophy, retinal, 4

An autosomal dominant retinal disease characterized by late-onset macular degeneration, with multiple drusen-like deposits, macular geographic atrophy, and choroidal neovascularization. Patients also exhibit extensive retinal dysfunction with impaired rod function.

VIAS REACTOME (1)
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (1)
macular dystrophy, retinal, 4
HGNC:HGNC:11891UniProt:P05452
TUBGCP6Gamma-tubulin complex component 6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the gamma-tubulin ring complex (gTuRC) which mediates microtubule nucleation (PubMed:11694571, PubMed:38305685, PubMed:38609661, PubMed:39321809). The gTuRC regulates the minus-end nucleation of alpha-beta tubulin heterodimers that grow into microtubule protafilaments, a critical step in centrosome duplication and spindle formation (PubMed:38305685, PubMed:38609661, PubMed:39321809)

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (2)
Recruitment of mitotic centrosome proteins and complexesRecruitment of NuMA to mitotic centrosomes
MECANISMO DE DOENÇA

Microcephaly and chorioretinopathy, autosomal recessive, 1

A syndrome characterized by microcephaly, cognitive impairment, underdeveloped retina and choroid, and epilepsy in some patients. The more anterior parts of the retina, near the periphery and pars plana, have a grayish hue and diminutive vasculature similar to retinopathy of prematurity. Visual impairment becomes evident during the first year of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
124.7 TPM
Cérebro - Hemisfério cerebelar
109.4 TPM
Tireoide
83.5 TPM
Pituitária
80.3 TPM
Cervix Endocervix
66.9 TPM
OUTRAS DOENÇAS (1)
microcephaly and chorioretinopathy 1
HGNC:18127UniProt:Q96RT7
ARL2BPADP-ribosylation factor-like protein 2-binding proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Together with ARL2, plays a role in the nuclear translocation, retention and transcriptional activity of STAT3. May play a role as an effector of ARL2

LOCALIZAÇÃO

CytoplasmMitochondrion intermembrane spaceCytoplasm, cytoskeleton, microtubule organizing center, centrosomeNucleusCytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (1)
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
MECANISMO DE DOENÇA

Retinitis pigmentosa 82 with or without situs inversus

An autosomal recessive disorder characterized by variable association of retinitis pigmentosa with situs inversus. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. Situs inversus is a congenital abnormality in which organs in the thorax and the abdomen are opposite to their normal positions due to lateral transposition.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
retinitis pigmentosa with or without situs inversusretinitis pigmentosa
HGNC:17146UniProt:Q9Y2Y0
IMPDH1Inosine-5'-monophosphate dehydrogenase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (3)
Purine ribonucleoside monophosphate biosynthesisAzathioprine ADMEPotential therapeutics for SARS
MECANISMO DE DOENÇA

Retinitis pigmentosa 10

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
172.5 TPM
Baço
95.6 TPM
Fibroblastos
82.8 TPM
Adipose Visceral Omentum
79.9 TPM
Tecido adiposo
66.9 TPM
OUTRAS DOENÇAS (4)
Leber congenital amaurosis 11retinitis pigmentosa 10retinitis pigmentosaLeber congenital amaurosis
HGNC:6052UniProt:P20839
KIF11Kinesin-like protein KIF11Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Motor protein required for establishing a bipolar spindle and thus contributing to chromosome congression during mitosis (PubMed:19001501, PubMed:37728657). Required in non-mitotic cells for transport of secretory proteins from the Golgi complex to the cell surface (PubMed:23857769)

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeleton, spindle pole

VIAS BIOLÓGICAS (3)
KinesinsCOPI-dependent Golgi-to-ER retrograde trafficMHC class II antigen presentation
MECANISMO DE DOENÇA

Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development

An autosomal dominant disorder that involves an overlapping but variable spectrum of central nervous system and ocular developmental anomalies. Microcephaly ranges from mild to severe and is often associated with mild to moderate developmental delay and a characteristic facial phenotype with upslanting palpebral fissures, broad nose with rounded tip, long philtrum with thin upper lip, prominent chin, and prominent ears. Chorioretinopathy is the most common eye abnormality, but retinal folds, microphthalmia, and myopic and hypermetropic astigmatism have also been reported, and some individuals have no overt ocular phenotype. Congenital lymphedema, when present, is typically confined to the dorsa of the feet, and lymphoscintigraphy reveals the absence of radioactive isotope uptake from the webspaces between the toes.

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
53.2 TPM
Testículo
18.2 TPM
Fibroblastos
17.5 TPM
Esôfago - Mucosa
10.3 TPM
Skin Sun Exposed Lower leg
4.6 TPM
OUTRAS DOENÇAS (1)
microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability
HGNC:6388UniProt:P52732
PDE6ARod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alphaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Rod-specific cGMP phosphodiesterase that catalyzes the hydrolysis of 3',5'-cyclic GMP (PubMed:20940301). This protein participates in processes of transmission and amplification of the visual signal

LOCALIZAÇÃO

Cell membraneCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (1)
Ca2+ pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 43

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
4.6 TPM
Pituitária
3.1 TPM
Esôfago - Mucosa
1.5 TPM
Cólon transverso
1.1 TPM
Glândula adrenal
0.8 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 43retinitis pigmentosa
HGNC:8785UniProt:P16499
RPGRIP1X-linked retinitis pigmentosa GTPase regulator-interacting protein 1Candidate gene tested inTolerante
FUNÇÃO

May function as scaffolding protein. Required for normal location of RPGR at the connecting cilium of photoreceptor cells. Required for normal disk morphogenesis and disk organization in the outer segment of photoreceptor cells and for survival of photoreceptor cells

LOCALIZAÇÃO

Cell projection, cilium

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateAnchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Leber congenital amaurosis 6

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
40.1 TPM
Baço
1.2 TPM
Intestino delgado
0.7 TPM
Sangue
0.6 TPM
Mama
0.5 TPM
OUTRAS DOENÇAS (5)
Leber congenital amaurosis 6cone-rod dystrophy 13Leber congenital amaurosisMeckel syndrome
HGNC:13436UniProt:Q96KN7
CFHComplement factor HCandidate gene tested inAltamente restrito
FUNÇÃO

Glycoprotein that plays an essential role in maintaining a well-balanced immune response by modulating complement activation. Acts as a soluble inhibitor of complement, where its binding to self markers such as glycan structures prevents complement activation and amplification on cell surfaces (PubMed:21285368, PubMed:21317894, PubMed:25402769). Accelerates the decay of the complement alternative pathway (AP) C3 convertase C3bBb, thus preventing local formation of more C3b, the central player of

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
Regulation of Complement cascade
MECANISMO DE DOENÇA

Basal laminar drusen

Drusen are extracellular deposits that accumulate below the retinal pigment epithelium on Bruch membrane. Basal laminar drusen refers to an early adult-onset drusen phenotype that shows a pattern of uniform small, slightly raised yellow subretinal nodules randomly scattered in the macula. In later stages, these drusen often become more numerous, with clustered groups of drusen scattered throughout the retina. In time these small basal laminar drusen may expand and ultimately lead to a serous pigment epithelial detachment of the macula that may result in vision loss.

OUTRAS DOENÇAS (10)
complement factor H deficiencybasal laminar drusendense deposit diseaseDoyne honeycomb retinal dystrophy
HGNC:4883UniProt:P08603
LRATLecithin retinol acyltransferaseCandidate gene tested inTolerante
FUNÇÃO

Transfers the acyl group from the sn-1 position of phosphatidylcholine to all-trans retinol, producing all-trans retinyl esters (PubMed:9920938). Retinyl esters are storage forms of vitamin A (Probable). LRAT plays a critical role in vision (Probable). It provides the all-trans retinyl ester substrates for the isomerohydrolase which processes the esters into 11-cis-retinol in the retinal pigment epithelium; due to a membrane-associated alcohol dehydrogenase, 11 cis-retinol is oxidized and conver

LOCALIZAÇÃO

Endoplasmic reticulum membraneRough endoplasmic reticulumEndosome, multivesicular bodyCytoplasm, perinuclear region

VIAS BIOLÓGICAS (2)
The canonical retinoid cycle in rods (twilight vision)Retinoid metabolism and transport
MECANISMO DE DOENÇA

Leber congenital amaurosis 14

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
3.3 TPM
Brain Spinal cord cervical c-1
3.1 TPM
Tireoide
2.8 TPM
Cólon sigmoide
2.4 TPM
Nervo tibial
2.2 TPM
OUTRAS DOENÇAS (4)
Leber congenital amaurosis 14severe early-childhood-onset retinal dystrophyretinitis pigmentosaLeber congenital amaurosis
HGNC:6685UniProt:O95237
TTC8Tetratricopeptide repeat protein 8Candidate gene tested inTolerante
FUNÇÃO

The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the c

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, cilium membraneCytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satelliteCell projection, cilium

VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
MECANISMO DE DOENÇA

Retinitis pigmentosa 51

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
40.7 TPM
Pituitária
30.5 TPM
Testículo
20.5 TPM
Glândula adrenal
19.6 TPM
Tireoide
18.3 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 51Bardet-Biedl syndrome 8retinitis pigmentosaBardet-Biedl syndrome
HGNC:20087UniProt:Q8TAM2
RAB28Ras-related protein Rab-28Candidate gene tested inTolerante
FUNÇÃO

The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes (PubMed:8647132). Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion (PubMed:8647132). RAB28 is required for shedding and phagocytosis of cone cell outer segments (OS) discs

LOCALIZAÇÃO

Cell membraneCytoplasm, cytoskeleton, cilium basal bodyCytoplasmNucleus

MECANISMO DE DOENÇA

Cone-rod dystrophy 18

A form of cone-rod dystrophy, an inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
44.8 TPM
Nervo tibial
36.4 TPM
Pituitária
35.5 TPM
Fallopian Tube
33.6 TPM
Cervix Endocervix
32.0 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
cone-rod dystrophy 18cone-rod dystrophy
HGNC:9768UniProt:P51157
AIPL1Aryl-hydrocarbon-interacting protein-like 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May be important in protein trafficking and/or protein folding and stabilization

LOCALIZAÇÃO

CytoplasmNucleus

MECANISMO DE DOENÇA

Leber congenital amaurosis 4

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

OUTRAS DOENÇAS (4)
Leber congenital amaurosis 4AIPL1-related retinopathycone-rod dystrophyLeber congenital amaurosis
HGNC:359UniProt:Q9NZN9
RAX2Retina and anterior neural fold homeobox protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in modulating the expression of photoreceptor specific genes. Binds to the Ret-1 and Bat-1 element within the rhodopsin promoter

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Macular degeneration, age-related, 6

A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane.

EXPRESSÃO TECIDUAL(Baixa expressão)
Pituitária
1.9 TPM
Fallopian Tube
0.9 TPM
Útero
0.7 TPM
Cervix Endocervix
0.1 TPM
Testículo
0.1 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 95cone-rod dystrophy 11age related macular degeneration 6cone-rod dystrophy
HGNC:18286UniProt:Q96IS3
GPR179Probable G-protein coupled receptor 179Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Orphan receptor involved in vision (PubMed:22325362, PubMed:24084093). Required for signal transduction through retinal depolarizing bipolar cells (PubMed:22325362). Acts as an atypical G-protein coupled receptor that recruits and regulates the R7 group RGS-GNB5 complexes instead of activating G proteins: promotes the GTPase activator activity of R7 RGS proteins, increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form (By similarity). A

LOCALIZAÇÃO

Cell membranePostsynaptic cell membraneCell projection, dendrite

MECANISMO DE DOENÇA

Night blindness, congenital stationary, 1E

An autosomal recessive, non-progressive retinal disorder characterized by impaired night vision, absence of the electroretinogram (ERG) b-wave, and variable degrees of involvement of other visual functions. Affected individuals have an ERG waveform that lacks the b-wave because of failure to transmit the photoreceptor signal through the retinal depolarizing bipolar cells.

EXPRESSÃO TECIDUAL(Baixa expressão)
Cérebro - Hemisfério cerebelar
2.5 TPM
Cerebelo
2.5 TPM
Córtex cerebral
1.5 TPM
Brain Frontal Cortex BA9
1.4 TPM
Brain Nucleus accumbens basal ganglia
1.3 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (1)
congenital stationary night blindness 1E
HGNC:31371UniProt:Q6PRD1
IMPG2Interphotoreceptor matrix proteoglycan 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Chondroitin sulfate- and hyaluronan-binding proteoglycan involved in the organization of interphotoreceptor matrix; may participate in the maturation and maintenance of the light-sensitive photoreceptor outer segment. Binds heparin

LOCALIZAÇÃO

Photoreceptor outer segment membranePhotoreceptor inner segment membraneSecreted, extracellular space, extracellular matrix, interphotoreceptor matrix

MECANISMO DE DOENÇA

Retinitis pigmentosa 56

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Fallopian Tube
0.8 TPM
Rim - Medula
0.7 TPM
Artéria coronária
0.5 TPM
Nervo tibial
0.4 TPM
Baço
0.4 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 56vitelliform macular dystrophy 5retinitis pigmentosaadult-onset foveomacular vitelliform dystrophy
HGNC:18362UniProt:Q9BZV3
RCBTB1RCC1 and BTB domain-containing protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in cell cycle regulation by chromatin remodeling

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Retinal dystrophy with or without extraocular anomalies

An autosomal recessive disease characterized by progressive retinal dystrophy, chorioretinal macular atrophy, reduced cone and rod responses on ERG, and decrease visual acuity. Extraocular anomalies are variably present in some patients and include pulmonary fibrosis, sensorineural hearing loss, and endocrine features such as goiter and primary ovarian insufficiency.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
77.1 TPM
Brain Spinal cord cervical c-1
37.8 TPM
Glândula adrenal
33.7 TPM
Útero
30.5 TPM
Substância negra
29.0 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
RCBTB1-related retinopathyreticular dystrophy of the retinal pigment epithelium
HGNC:18243UniProt:Q8NDN9
PAX6Paired box protein Pax-6Candidate gene tested inAltamente restrito
FUNÇÃO

Transcription factor with important functions in the development of the eye, nose, central nervous system and pancreas. Required for the differentiation of pancreatic islet alpha cells (By similarity). Competes with PAX4 in binding to a common element in the glucagon, insulin and somatostatin promoters. Regulates specification of the ventral neuron subtypes by establishing the correct progenitor domains (By similarity). Acts as a transcriptional repressor of NFATC1-mediated gene expression (By s

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (5)
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)Regulation of gene expression in beta cellsActivation of anterior HOX genes in hindbrain development during early embryogenesisFormation of the anterior neural plateSynthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)
MECANISMO DE DOENÇA

Aniridia 1

A congenital, bilateral, panocular disorder characterized by complete absence of the iris or extreme iris hypoplasia. Aniridia is not just an isolated defect in iris development but it is associated with macular and optic nerve hypoplasia, cataract, corneal changes, nystagmus. Visual acuity is generally low but is unrelated to the degree of iris hypoplasia. Glaucoma is a secondary problem causing additional visual loss over time.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
40.8 TPM
Cerebelo
36.9 TPM
Córtex cerebral
3.5 TPM
Brain Caudate basal ganglia
3.4 TPM
Brain Anterior cingulate cortex BA24
3.3 TPM
OUTRAS DOENÇAS (17)
coloboma, ocular, autosomal dominantisolated optic nerve hypoplasiaautosomal dominant keratitisfoveal hypoplasia 1
HGNC:8620UniProt:P26367
IFT172Intraflagellar transport protein 172 homologCandidate gene tested inTolerante
FUNÇÃO

Required for the maintenance and formation of cilia. Plays an indirect role in hedgehog (Hh) signaling, cilia being required for all activity of the hedgehog pathway (By similarity)

LOCALIZAÇÃO

Cell projection, cilium

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateIntraflagellar transport
MECANISMO DE DOENÇA

Short-rib thoracic dysplasia 10 with or without polydactyly

A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
57.3 TPM
Pituitária
51.2 TPM
Ovário
41.6 TPM
Tireoide
30.7 TPM
Cerebelo
30.2 TPM
OUTRAS DOENÇAS (7)
retinitis pigmentosa 71Bardet-Biedl syndrome 20short-rib thoracic dysplasia 10 with or without polydactylyshort-rib thoracic dysplasia 9 with or without polydactyly
HGNC:30391UniProt:Q9UG01
TREX1Three-prime repair exonuclease 1Candidate gene tested inTolerante
FUNÇÃO

Major cellular 3'-to-5' DNA exonuclease which digests single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA) with mismatched 3' termini (PubMed:10391904, PubMed:10393201, PubMed:17293595). Prevents cell-intrinsic initiation of autoimmunity (PubMed:10391904, PubMed:10393201, PubMed:17293595). Acts by metabolizing DNA fragments from endogenous retroelements, including L1, LTR and SINE elements (PubMed:10391904, PubMed:10393201, PubMed:17293595). Plays a key role in degradation of DNA fragment

LOCALIZAÇÃO

NucleusCytoplasm, cytosolEndoplasmic reticulum membrane

VIAS BIOLÓGICAS (2)
IRF3-mediated induction of type I IFNRegulation by TREX1
MECANISMO DE DOENÇA

Aicardi-Goutieres syndrome 1

A form of Aicardi-Goutieres syndrome, a genetically heterogeneous disease characterized by cerebral atrophy, leukoencephalopathy, intracranial calcifications, chronic cerebrospinal fluid (CSF) lymphocytosis, increased CSF alpha-interferon, and negative serologic investigations for common prenatal infection. Clinical features as thrombocytopenia, hepatosplenomegaly and elevated hepatic transaminases along with intermittent fever may erroneously suggest an infective process. Severe neurological dysfunctions manifest in infancy as progressive microcephaly, spasticity, dystonic posturing and profound psychomotor retardation. Death often occurs in early childhood.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
80.6 TPM
Baço
45.2 TPM
Skin Sun Exposed Lower leg
42.6 TPM
Skin Not Sun Exposed Suprapubic
42.3 TPM
Pituitária
42.0 TPM
OUTRAS DOENÇAS (6)
retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestationschilblain lupus 1Aicardi-Goutieres syndrome 1Aicardi-Goutieres syndrome
HGNC:12269UniProt:Q9NSU2
RBP4Retinol-binding protein 4Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Retinol-binding protein that mediates retinol transport in blood plasma (PubMed:5541771). Delivers retinol from the liver stores to the peripheral tissues (Probable). Transfers the bound all-trans retinol to STRA6, that then facilitates retinol transport across the cell membrane (PubMed:22665496)

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
Retinoid metabolism disease events
MECANISMO DE DOENÇA

Retinal dystrophy, iris coloboma, and comedogenic acne syndrome

A disease characterized by retinal degeneration, ocular colobomas involving both the anterior and posterior segment, impaired night vision and loss of visual acuity. Additional characteristic features include developmental abnormalities and severe acne.

EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
4153.5 TPM
Tecido adiposo
554.2 TPM
Pituitária
376.5 TPM
Adipose Visceral Omentum
289.3 TPM
Mama
162.8 TPM
OUTRAS DOENÇAS (3)
progressive retinal dystrophy due to retinol transport defectmicrophthalmia, isolated, with coloboma 10microphthalmia, isolated, with coloboma
HGNC:9922UniProt:P02753
TUBB4BTubulin beta-4B chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasm, cytoskeleton, flagellum axoneme

VIAS BIOLÓGICAS (10)
HCMV Early EventsPKR-mediated signalingGap junction assemblyAggrephagyAssembly and cell surface presentation of NMDA receptors
MECANISMO DE DOENÇA

Leber congenital amaurosis with early-onset deafness

An autosomal dominant disease characterized by severe retinal degeneration and sensorineural hearing loss. Symptoms occur within the first decade of life. Onset at birth is observed in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
1825.9 TPM
Fibroblastos
703.0 TPM
Esôfago - Mucosa
500.6 TPM
Skin Not Sun Exposed Suprapubic
374.1 TPM
Linfócitos
355.3 TPM
OUTRAS DOENÇAS (2)
Leber congenital amaurosis with early-onset deafnessLeber congenital amaurosis
HGNC:20771UniProt:P68371
RP1Microtubule-associated protein RP/EB family member 2Candidate gene tested inTolerante
FUNÇÃO

Adapter protein that is involved in microtubule polymerization, and spindle function by stabilizing microtubules and anchoring them at centrosomes. Therefore, ensures mitotic progression and genome stability (PubMed:27030108). Acts as a central regulator of microtubule reorganization in apico-basal epithelial differentiation (By similarity). Plays a role during oocyte meiosis by regulating microtubule dynamics (By similarity). Participates in neurite growth by interacting with plexin B3/PLXNB3 a

LOCALIZAÇÃO

Cytoplasm, cytoskeleton

MECANISMO DE DOENÇA

Skin creases, congenital symmetric circumferential, 2

An autosomal dominant disease characterized by multiple, symmetric, circumferential rings of folded skin, affecting primarily the limbs. Affected individuals also exhibit intellectual disability, cleft palate, and dysmorphic features.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
0.9 TPM
Pulmão
0.8 TPM
Rim - Medula
0.3 TPM
Fallopian Tube
0.3 TPM
Estômago
0.2 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 1retinitis pigmentosa
HGNC:10263UniProt:Q15555
ACO2Aconitate hydratase, mitochondrialDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalyzes the isomerization of citrate to isocitrate via cis-aconitate

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (3)
Citric acid cycle (TCA cycle)Maturation of TCA enzymes and regulation of TCA cycleMitochondrial protein degradation
MECANISMO DE DOENÇA

Infantile cerebellar-retinal degeneration

A severe autosomal recessive neurodegenerative disorder characterized by onset between ages 2 and 6 months of truncal hypotonia, athetosis, seizures, and ophthalmologic abnormalities, particularly optic atrophy and retinal degeneration. Affected individuals show profound psychomotor retardation, with only some achieving rolling, sitting, or recognition of family. Brain MRI shows progressive cerebral and cerebellar degeneration.

OUTRAS DOENÇAS (3)
infantile cerebellar-retinal degenerationoptic atrophy 9obsolete autosomal recessive optic atrophy
HGNC:118UniProt:Q99798
CFAP418Cilia- and flagella-associated protein 418Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in photoreceptor outer segment disk morphogenesis (By similarity)

LOCALIZAÇÃO

CytoplasmPhotoreceptor inner segment

MECANISMO DE DOENÇA

Cone-rod dystrophy 16

An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

OUTRAS DOENÇAS (5)
cone-rod dystrophy 16bardet-biedl syndrome 21cone-rod dystrophyretinitis pigmentosa
HGNC:27232UniProt:Q96NL8
RLBP1Retinaldehyde-binding protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Soluble retinoid carrier essential the proper function of both rod and cone photoreceptors. Participates in the regeneration of active 11-cis-retinol and 11-cis-retinaldehyde, from the inactive 11-trans products of the rhodopsin photocycle and in the de novo synthesis of these retinoids from 11-trans metabolic precursors. The cycling of retinoids between photoreceptor and adjacent pigment epithelium cells is known as the 'visual cycle'

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (3)
The canonical retinoid cycle in rods (twilight vision)The retinoid cycle in cones (daylight vision)Defective visual phototransduction due to RDH5 loss of function
MECANISMO DE DOENÇA

Bothnia retinal dystrophy

A type of retinitis punctata albescens. Affected individuals show night blindness from early childhood with features consistent with retinitis punctata albescens and macular degeneration.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Caudate basal ganglia
11.3 TPM
Córtex cerebral
11.2 TPM
Brain Putamen basal ganglia
10.5 TPM
Brain Frontal Cortex BA9
9.5 TPM
Brain Anterior cingulate cortex BA24
7.6 TPM
OUTRAS DOENÇAS (5)
fundus albipunctatusNewfoundland cone-rod dystrophyBothnia retinal dystrophyretinitis pigmentosa
HGNC:10024UniProt:P12271
FBN2Fibrillin-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Fibrillins are structural components of 10-12 nm extracellular calcium-binding microfibrils, which occur either in association with elastin or in elastin-free bundles. Fibrillin-2-containing microfibrils regulate the early process of elastic fiber assembly. Regulates osteoblast maturation by controlling TGF-beta bioavailability and calibrating TGF-beta and BMP levels, respectively Hormone secreted by trophoblasts that promotes trophoblast invasiveness (PubMed:32329225). Has glucogenic activity:

LOCALIZAÇÃO

SecretedSecreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Elastic fibre formation
MECANISMO DE DOENÇA

Contractural arachnodactyly, congenital

An autosomal dominant connective tissue disorder characterized by contractures, arachnodactyly, scoliosis, and crumpled ears.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fibroblastos
126.7 TPM
Testículo
6.0 TPM
Glândula adrenal
5.0 TPM
Esôfago - Muscular
2.9 TPM
Coração - Ventrículo esquerdo
2.7 TPM
OUTRAS DOENÇAS (2)
macular degeneration, early-onsetcongenital contractural arachnodactyly
HGNC:3604UniProt:P35556
USH2AUsherinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in hearing and vision as member of the USH2 complex. In the inner ear, required for the maintenance of the hair bundle ankle formation, which connects growing stereocilia in developing cochlear hair cells. In retina photoreceptors, the USH2 complex is required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport

LOCALIZAÇÃO

Cell projection, stereocilium membraneSecreted

MECANISMO DE DOENÇA

Usher syndrome 2A

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.2 TPM
Fígado
0.8 TPM
Cérebro - Hemisfério cerebelar
0.2 TPM
Cerebelo
0.2 TPM
Coração - Átrio
0.2 TPM
OUTRAS DOENÇAS (5)
retinitis pigmentosa 39Usher syndrome type 2AUsher syndromeretinitis pigmentosa
HGNC:12601UniProt:O75445

Medicamentos e terapias

PEGAPTANIB SODIUMPhase 4

Mecanismo: Vascular endothelial growth factor A antagonist

RANIBIZUMABPhase 4

Mecanismo: Vascular endothelial growth factor A inhibitor

AFLIBERCEPTPhase 4

Mecanismo: Placenta growth factor inhibitor

BROLUCIZUMABPhase 4

Mecanismo: Vascular endothelial growth factor A inhibitor

FARICIMABPhase 4

Mecanismo: Angiopoietin-2 inhibitor

VORETIGENE NEPARVOVECPhase 4

Mecanismo: Retinoid isomerohydrolase exogenous gene

BEVACIZUMABPhase 3

Mecanismo: Vascular endothelial growth factor A inhibitor

TRIAMCINOLONE ACETONIDEPhase 3

Mecanismo: Glucocorticoid receptor agonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

406 variantes patogênicas registradas no ClinVar.

🧬 ROM1: GRCh37/hg19 11q12.1-13.3(chr11:56895955-69295402)x3 ()
🧬 ROM1: GRCh37/hg19 11p11.12-q13.1(chr11:50398499-63924462)x3 ()
🧬 ROM1: GRCh37/hg19 11q12.2-13.5(chr11:59923608-76272324)x3 ()
🧬 ROM1: GRCh37/hg19 11p13-q25(chr11:32799481-134938470)x3 ()
🧬 ROM1: NM_000327.4(ROM1):c.941G>A (p.Gly314Glu) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

125 vias biológicas associadas aos genes desta condição.

Collagen degradation The retinoid cycle in cones (daylight vision) G alpha (i) signalling events Opsins Defective visual phototransduction due to OPN1LW loss of function NRAGE signals death through JNK TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) G alpha (12/13) signalling events RHOA GTPase cycle RAC1 GTPase cycle The canonical retinoid cycle in rods (twilight vision) Activation of the phototransduction cascade Inactivation, recovery and regulation of the phototransduction cascade VxPx cargo-targeting to cilium Adherens junctions interactions Regulation of PLK1 Activity at G2/M Transition Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes Anchoring of the basal body to the plasma membrane Neutrophil degranulation AURKA Activation by TPX2 ABC-family proteins mediated transport Defective visual phototransduction due to ABCA4 loss of function RPGRIP1L RAB8A,10,13,14 exchange GDP for GTP PPARA activates gene expression Phase I - Functionalization of compounds Endogenous sterols Xenobiotics Aryl hydrocarbon receptor signalling Recognition and association of DNA glycosylase with site containing an affected pyrimidine Cleavage of the damaged pyrimidine Recognition and association of DNA glycosylase with site containing an affected purine Cleavage of the damaged purine Meiotic synapsis Packaging Of Telomere Ends Telomere Extension By Telomerase Polymerase switching on the C-strand of the telomere Processive synthesis on the C-strand of the telomere Telomere C-strand (Lagging Strand) Synthesis Telomere C-strand synthesis initiation Removal of the Flap Intermediate from the C-strand DNA Damage/Telomere Stress Induced Senescence Inhibition of DNA recombination at telomere BBSome-mediated cargo-targeting to cilium Citric acid cycle (TCA cycle) Mitochondrial protein degradation SUMOylation of transcription cofactors SUMOylation of SUMOylation proteins SUMOylation of immune response proteins Glutamate and glutamine metabolism mRNA Splicing - Major Pathway RA biosynthesis pathway Defective visual phototransduction due to RDH5 loss of function Ca2+ pathway Stimuli-sensing channels NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux Diseases of branched-chain amino acid catabolism PTEN Regulation Regulation of PTEN gene transcription FCERI mediated NF-kB activation TP53 Regulates Metabolic Genes Stabilization of p53 Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN) Regulation of TP53 Activity through Phosphorylation TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway Hedgehog 'off' state Intraflagellar transport Tight junction interactions Glycolysis OCT2 mediates tubular secretion of organic cations in the kidney OCT2 mediates tubular uptake of organic cations in the kidney SLC5A1 cotransports Glc,Gal with Na+ from extracellular region to cytosol Elastic fibre formation Molecules associated with elastic fibres mRNA Splicing - Minor Pathway Dengue Virus-Host Interactions Developmental Lineage of Pancreatic Ductal Cells Cell surface interactions at the vascular wall Dengue Virus Attachment and Entry Transphosphorylation of pLIMK1 Platelet degranulation Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane Purine ribonucleoside monophosphate biosynthesis Potential therapeutics for SARS Azathioprine ADME MHC class II antigen presentation COPI-dependent Golgi-to-ER retrograde traffic Kinesins Regulation of Complement cascade Retinoid metabolism and transport Defective visual phototransduction due to LRAT loss of function Regulation of gene expression in beta cells Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) Activation of anterior HOX genes in hindbrain development during early embryogenesis Formation of the anterior neural plate Regulation by TREX1 IRF3-mediated induction of type I IFN Retinoid metabolism disease events Defective visual phototransduction due to STRA6 loss of function Translocation of SLC2A4 (GLUT4) to the plasma membrane Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane Gap junction assembly Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand Prefoldin mediated transfer of substrate to CCT/TriC Formation of tubulin folding intermediates by CCT/TriC Post-chaperonin tubulin folding pathway Recycling pathway of L1 Cargo trafficking to the periciliary membrane RHO GTPases activate IQGAPs RHO GTPases Activate Formins COPI-mediated anterograde transport COPI-independent Golgi-to-ER retrograde traffic Mitotic Prometaphase The role of GTSE1 in G2/M progression after G2 checkpoint Carboxyterminal post-translational modifications of tubulin RP105:MD1 Mitochondrial protein import Maturation of TCA enzymes and regulation of TCA cycle Degradation of the extracellular matrix

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado6
3Fase 32
Medicamentos catalogadosEnsaios clínicos· 8 medicamentos · 0 ensaios
✓ Aprovados — podem ser usados hoje
PEGAPTANIB SODIUMRANIBIZUMABAFLIBERCEPTBROLUCIZUMABFARICIMABVORETIGENE NEPARVOVEC
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Distrofia da retina, genética

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Distrofia da retina, genética.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Distrofia da retina, genética

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. [Identification of the molecular bases of retinal dystrophies: two divergent situations and their implications].
    Bull Acad Natl Med· 2009· PMID 19718988recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:71862(Orphanet)
  2. MONDO:0019118(MONDO)
  3. GARD:18916(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q5811451(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Distrofia da retina, genética
Compêndio · Raras BR

Distrofia da retina, genética

ORPHA:71862 · MONDO:0019118
CID-10
H35.5 · Distrofias hereditárias da retina
Medicamentos
8 registrados
UMLS
C0854723
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades